Stresser DM[au] - Search Results

Year	Number of Results
1994	2
1995	4
1996	1
1997	2
1998	2
1999	2
2000	5
2001	2
2002	3
2003	1
2004	1
2006	2
2009	3
2010	1
2012	1
2013	1
2014	2
2016	2
2017	1
2018	1
2020	2
2021	4
2022	0

1

In Vitro Drug Metabolism Using Liver Microsomes.

Knights KM, Stresser DM, Miners JO, Crespi CL. Knights KM, et al. Among authors: stresser dm. Curr Protoc Pharmacol. 2016 Sep 16;74:7.8.1-7.8.24. doi: 10.1002/cpph.9. Curr Protoc Pharmacol. 2016. PMID: 27636111

2

Exploring concepts of in vitro time-dependent CYP inhibition assays.

Stresser DM, Mao J, Kenny JR, Jones BC, Grime K. Stresser DM, et al. Expert Opin Drug Metab Toxicol. 2014 Feb;10(2):157-74. doi: 10.1517/17425255.2014.856882. Epub 2013 Nov 21. Expert Opin Drug Metab Toxicol. 2014. PMID: 24256452 Review.

3

Case Study 3: Criticality of High-Quality Curve Fitting-"Getting a K_m,app" Isn't as Simple as It May Seem.

Stresser DM, Emami-Riedmaier A. Stresser DM, et al. Methods Mol Biol. 2021;2342:653-664. doi: 10.1007/978-1-0716-1554-6_22. Methods Mol Biol. 2021. PMID: 34272710 Review.

4

Cardiovascular microphysiological systems (CVMPS) for safety studies - a pharma perspective.

Pointon A, Maher J, Davis M, Baker T, Cichocki J, Ramsden D, Hale C, Kolaja KL, Levesque P, Sura R, Stresser DM, Gintant G. Pointon A, et al. Among authors: stresser dm. Lab Chip. 2021 Feb 9;21(3):458-472. doi: 10.1039/d0lc01040e. Lab Chip. 2021. PMID: 33471007

5

In vitro and pharmacophore insights into CYP3A enzymes.

Ekins S, Stresser DM, Williams JA. Ekins S, et al. Among authors: stresser dm. Trends Pharmacol Sci. 2003 Apr;24(4):161-6. doi: 10.1016/s0165-6147(03)00049-x. Trends Pharmacol Sci. 2003. PMID: 12707001 Review.

6

Evaluation of Tissue Stem Cell-Derived Human Intestinal Organoids, a Physiologically Relevant Model to Evaluate Cytochrome P450 Induction in Gut.

Stresser DM, Sun J, Wilson SS. Stresser DM, et al. Drug Metab Dispos. 2021 Mar;49(3):245-253. doi: 10.1124/dmd.120.000281. Epub 2020 Dec 18. Drug Metab Dispos. 2021. PMID: 33355212

7

David Kupfer: a career retrospective.

Stresser DM. Stresser DM. Drug Metab Rev. 2006;38(1-2):3-12. doi: 10.1080/03602530600569745. Drug Metab Rev. 2006. PMID: 16684644

8

Prosubstrates of CYP3A4, the major human hepatic cytochrome P450: transformation into substrates by other P450 isoforms.

Stresser DM, Kupfer D. Stresser DM, et al. Biochem Pharmacol. 1998 Jun 1;55(11):1861-71. doi: 10.1016/s0006-2952(98)00060-4. Biochem Pharmacol. 1998. PMID: 9714305

9

Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole.

Stresser DM, Perloff ES, Mason AK, Blanchard AP, Dehal SS, Creegan TP, Singh R, Gangl ET. Stresser DM, et al. Drug Metab Dispos. 2016 Aug;44(8):1424-30. doi: 10.1124/dmd.116.070193. Epub 2016 May 5. Drug Metab Dispos. 2016. PMID: 27149898

10

Enrichment-free High-throughput Liquid Chromatography-Multiple-Reaction Monitoring Quantification of Cytochrome P450 Proteins in Plated Human Hepatocytes Direct from 96-Well Plates Enables Routine Protein Induction Measurements.

Savaryn JP, Liu N, Sun J, Ma J, Stresser DM, Jenkins G. Savaryn JP, et al. Among authors: stresser dm. Drug Metab Dispos. 2020 Jul;48(7):594-602. doi: 10.1124/dmd.120.090480. Epub 2020 Apr 29. Drug Metab Dispos. 2020. PMID: 32350061

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results